Compare Wix.Com Ltd (WIX) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Wix.Com Ltd vs Zoetis Inc — how do they compare? Wix.Com Ltd trades at $73.87 (market cap $3.04B), while Zoetis Inc trades at $73.65 (market cap $30.40B). The key difference: Zoetis Inc is far larger — about 10× Wix.Com Ltd's market cap, and Zoetis Inc pays a 2.88% dividend while Wix.Com Ltd pays none. Which is the better fit depends on your goals.
| WIX | ZTS | |
|---|---|---|
Market Cap | $3.04B | $30.40B |
Sector | Technology | Health |
52-Week High | $184.24 | $150.61 |
52-Week Low | $40.43 | $71.91 |
Enterprise Value | $4.12B | $37.96B |
Dividend Yield | — | 2.88% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
WIX trades at $72.72, down 4.58% amid technical bearish signals and multiple securities class action lawsuits. The company shows revenue growth to $1.99B in 2025 but faces profitability challenges with a negative net income margin of -8.19%. Recent earnings were mixed with Q1 2026 missing expectations while Q2 2026 beat estimates. Cash flow trends show operational strength but significant investing outflows.
Analyst consensus remains positive with 63% buy ratings and $73.36 price target, but legal risks and competitive pressures create headwinds. The stock presents a high-risk opportunity with potential upside if legal issues resolve and AI product execution improves, though current technical weakness suggests caution.
Zoetis (ZTS) trades at $73.6, down 2.92% on the day, near its 52-week low amid bearish technical signals. The stock shows strong fundamentals with a P/E of 12, net margin of 27.69%, and consistent earnings beats, but faces headwinds from weak U.S. companion animal sales and reduced 2026 guidance. Recent news includes an FDA emergency use authorization for Simparica Trio and participation in healthcare conferences.
The outlook is mixed: valuation appears attractive with a consensus price target of $93.40, but near-term risks include competitive pressures and soft pet health demand. Long-term investors may find value in its profitability and market dominance, though volatility persists from sector challenges and investor sentiment shifts.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Wix.Com Ltd
Wix.com Ltd is a cloud-based development platform provider for millions of registered users worldwide. The company is engaged in web development and management that provides an easy-to-use powerful cloud-based platform of products through a freemium model. Its core products consist of three web editors: the Wix Editor, intended for users with basic technological skills, Wix ADI, intended for novice users and Corvid, intended for more tech-savvy users. The company's web development technology is built based on HTML5 and offers HTML5 compatible capabilities, web design and layout tools, domain hosting, and other marketing and workflow management applications and services. The geographic segments include North America, Europe, Latin America, Asia and others.
Read more on WIX →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
